NCT00240305View on ClinicalTrials.gov

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

May 31, 2006

Conditions
Metabolic SyndromeDyslipidemia
Interventions
DRUG

Rosuvastatin

Trial Locations (1)

Unknown

Research Site, Perth

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY